Botox vs. Dysport: REMS is a New wrinkle in Big Market
Executive Summary
A marketing battle with an unusual twist is brewing between Allergan's popular anti-wrinkle agent Botox and new-to-the-block Dysport, from Ipsen-Medicis. Both sides are citing their REMS (Risk Evaluation and Mitigation Strategy) as a key competitive advantage.You may also be interested in...
Aesthetics Market: Fillers May Offer Bright Spot in Tough Times
Living With REMS: The New Regulatory Model Meets Commercial Reality
Living With REMS: The New Regulatory Model Meets Commercial Reality
Need a specific report? 1000+ reports available
Buy Reports